HWM
AGIO icon

Hemington Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hemington Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Buy
15
+9
+150% +$339 ﹤0.01% 1515
2025
Q2 		$0 Sell
6
-15
-71% -$455 ﹤0.01% 1488
2025
Q1 		$0 Sell
21
-5
-19% -$166 ﹤0.01% 1486
2024
Q4 		$0 Buy
26
+10
+63% +$470 ﹤0.01% 1521
2024
Q3 		$0 Buy
+16
New +$727 ﹤0.01% 1462

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Hemington Wealth Management's AGIO Position: Q3 2025 in Review

Hemington Wealth Management increased its Agios Pharmaceuticals (AGIO) stake by 150% in Q3 2025, buying an estimated $339 and bringing the position to 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Hemington Wealth Management first reported a position in AGIO in Q3 2024 and has held it in 5 quarters since. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Hemington Wealth Management held 15 shares of Agios Pharmaceuticals worth $0 as of Q3 2025.
  • Hemington Wealth Management bought 9 Agios Pharmaceuticals shares in Q3 2025, an estimated $339.
  • Agios Pharmaceuticals made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1515 holding.
  • Hemington Wealth Management first reported a position in Agios Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.